chr20-56359070-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_080821.3(FAM210B):āc.65C>Gā(p.Ala22Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000516 in 1,356,264 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_080821.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM210B | NM_080821.3 | c.65C>G | p.Ala22Gly | missense_variant | 1/3 | ENST00000371384.4 | NP_543011.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM210B | ENST00000371384.4 | c.65C>G | p.Ala22Gly | missense_variant | 1/3 | 1 | NM_080821.3 | ENSP00000360437 | P1 | |
FAM210B | ENST00000437418.1 | upstream_gene_variant | 3 | ENSP00000389768 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151316Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000415 AC: 5AN: 1204948Hom.: 0 Cov.: 31 AF XY: 0.00000338 AC XY: 2AN XY: 591656
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151316Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73884
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The c.65C>G (p.A22G) alteration is located in exon 1 (coding exon 1) of the FAM210B gene. This alteration results from a C to G substitution at nucleotide position 65, causing the alanine (A) at amino acid position 22 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at